Practical guidance for echocardiography for cancer therapy-related cardiac dysfunction: 2026 focused update
Hidekazu Tanaka, Yuko Fukuda, Hirotsugu Yamada, Sakiko Miyazaki, Jiro Sakamoto, Masao Daimon · 2026
Read Practical guidance for echocardiography for cancer therapy-related cardiac dysfunction: 2026 focused update by Hidekazu Tanaka, Yuko Fukuda, Hirotsugu Yamada, Sakiko Miyazaki, Jiro Sakamoto, Masao Daimon (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13222306.txt.
Description
Hidekazu Tanaka and co-authors present updated guidance in 2026 on heart ultrasound for patients on cancer therapy. Cancer drugs can damage the heart, and longer survival makes spotting that damage early ever more important. The Japanese Society of Echocardiography first issued guidance in 2020, and this focused update reflects new evidence and imaging advances.
Two measures anchor the guidance: ejection fraction, the share of blood the heart pumps out, and global longitudinal strain, a finer gauge of muscle shortening. The document sets standard protocols before, during, and after drug therapy, plus long-term checks after chest radiation. It also covers heart inflammation linked to immune checkpoint drugs and stresses measurement quality, three-dimensional imaging, and AI support.
Catalog record
| CREATOR | Hidekazu Tanaka, Yuko Fukuda, Hirotsugu Yamada, Sakiko Miyazaki, Jiro Sakamoto, Masao Daimon |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 73 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |